ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $44,076,000 | -11.7% | 7,309,383 | -47.3% | 1.66% | -44.0% |
Q3 2019 | $49,912,000 | +34.3% | 13,864,383 | 0.0% | 2.97% | +49.5% |
Q2 2019 | $37,157,000 | -8.7% | 13,864,383 | +0.8% | 1.98% | -28.5% |
Q1 2019 | $40,698,000 | +86.2% | 13,749,383 | 0.0% | 2.78% | +36.5% |
Q4 2018 | $21,862,000 | -56.3% | 13,749,383 | +1.1% | 2.04% | -32.1% |
Q3 2018 | $50,032,000 | +30.6% | 13,595,704 | +0.4% | 3.00% | +8.4% |
Q2 2018 | $38,324,000 | -23.5% | 13,541,997 | +0.3% | 2.76% | -42.0% |
Q1 2018 | $50,074,000 | +28.3% | 13,496,902 | -0.4% | 4.76% | -26.8% |
Q4 2017 | $39,015,000 | +10.8% | 13,546,902 | +72.8% | 6.51% | +6.2% |
Q3 2017 | $35,201,000 | +382.2% | 7,839,766 | +392.9% | 6.13% | +298.3% |
Q2 2017 | $7,300,000 | +517.6% | 1,590,454 | +455.5% | 1.54% | +245.8% |
Q4 2016 | $1,182,000 | -93.4% | 286,285 | -87.0% | 0.44% | -91.8% |
Q3 2016 | $17,891,000 | -5.4% | 2,208,749 | -8.9% | 5.41% | -16.3% |
Q2 2016 | $18,908,000 | -4.3% | 2,424,136 | -5.3% | 6.46% | -9.9% |
Q1 2016 | $19,754,000 | -7.9% | 2,558,859 | +28.7% | 7.17% | +1.2% |
Q4 2015 | $21,460,000 | +19.9% | 1,988,914 | -23.2% | 7.09% | +27.5% |
Q3 2015 | $17,896,000 | -19.7% | 2,589,818 | +3.0% | 5.56% | -14.3% |
Q2 2015 | $22,287,000 | +39.3% | 2,515,433 | +55.0% | 6.49% | -10.2% |
Q1 2015 | $15,999,000 | -19.5% | 1,622,633 | 0.0% | 7.22% | -1.8% |
Q4 2014 | $19,877,000 | – | 1,622,633 | – | 7.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |